Sunday, September 23, 2018

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets

Company to Continue Operating Business and Serving Customers As Usual Aralez Pharmaceuticals Inc. announced today that it intends to enter into purchase agreements with two separate stalking-horse purchasers to sell its main operating businesses:  an...

MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia

Partners with Leading Australian Healthcare Products and Biological Supplier MiMedx Group, Inc., a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received regulatory approval from the Therapeutics Goods Administration (TGA)...

Autologous Stem Cell Therapy May Hold Key to Regeneration

USRM Chief Science Officer's Live Webinar Adds Voice to Debate U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced the...

Lilly Announces Agreement To Acquire ARMO BioSciences

.6 billion transaction will bolster Lilly's clinical portfolio with ARMO's lead immuno-oncology asset, pegilodecakin, which is being studied in multiple tumor types Eli Lilly and Company and ARMO BioSciences, Inc. today announced a definitive agreement...

Alcami Announces Industry-Leading Analytical Testing Turnaround Time

Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the advancement of the drug development process with the company's new, dramatically-reduced analytical testing turnaround...

Embrace® Active Scar Defense And Serena Williams Team Up To Talk About Motherhood, Healing...

Neodyne Biosciences, Inc. today announced they are partnering with professional tennis champion Serena Williams to raise awareness for its embrace® Active Scar Defense, an FDA cleared scar therapy system designed to prevent the formation of scar tissue...

AdvoCare International Announces the Promotion of Brett Blake as New CEO

AdvoCare International, L.P. today announced the promotion of Brett Blake to Chief Executive Officer, replacing industry-veteran Brian Connolly who served as interim-CEO during the extensive executive search. Connolly will continue to work closely with Brett serving as...

The Menarini Group Announced Marketing Authorization Application for Delafloxacin

The Menarini Group announced today that on March 6th 2017 it submitted a Marketing Authorization Application for delafloxacin at the European Medicines Agency (EMA) under the trade name Quofenix. The proposed indication for delafloxacin in Europe is the...

Thermal Imaging Market Size Poised to Reach $6.50 Billion At 9.1% CAGR By 2020...

The global Thermal Imaging Market size was valued at USD 3.2 billion in 2012 and is poised to reach USD 6.50 billion by 2020, with a CAGR of 9.1%. High demand of thermal imaging across residential and commercial sector is...

Heart Failure Treatment from Berlin Cures Shows Promise in Phase 1 Study

The first drug designed to eliminate autoantibodies that are a major cause of heart failure and to treat heart failure symptoms was effective and well-tolerated in a Phase 1 clinical study, according to...

Connect with us

4,539FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts